Press Releases

All Releases
Nektar Announces Positive Phase 2 Clinical Data from First Stage of NKTR-102 Study in Women with Platinum-Resistant Ovarian Cancer
Mar 8, 2010
PDF 13.3 KB
Nektar Therapeutics' President and CEO Howard W. Robin to Present at the 30th Annual Cowen and Company Healthcare Conference in Boston
Mar 2, 2010
PDF 8.4 KB
Nektar Therapeutics Reports Year-End 2009 Financial Results
Mar 2, 2010
PDF 17.6 KB
Nektar to Announce Year-End 2009 Financial Results on Tuesday, March 2, 2010, After Close of U.S.-Based Financial Markets
Feb 23, 2010
PDF 7.6 KB
Nektar Therapeutics Appoints R. Scott Greer to Board of Directors
Feb 2, 2010
PDF 8.7 KB
Nektar Therapeutics Announces Positive Topline Results for NKTR-102 From First Stage of Phase 2 Study in Platinum-Resistant Ovarian Cancer
Jan 12, 2010
PDF 13.5 KB
Nektar Therapeutics Names Stephen K. Doberstein, Ph.D. Senior Vice President and Chief Scientific Officer
Jan 6, 2010
PDF 9.1 KB
Nektar Therapeutics' President and CEO, Howard W. Robin, to Present at the 28th Annual J.P. Morgan Healthcare Conference in San Francisco, CA
Jan 6, 2010
PDF 6.2 KB
Dennis Winger Joins Nektar Therapeutics' Board of Directors
Dec 14, 2009
PDF 7.1 KB
Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer
Nov 30, 2009
PDF 8.7 KB
Nektar Therapeutics Reports Third Quarter 2009 Financial Results
Nov 4, 2009
PDF 17.5 KB
Nektar to Announce Financial Results for the Third Quarter of 2009 on Wednesday, November 4, 2009, After Close of U.S.-Based Financial Markets
Oct 29, 2009
PDF 7.1 KB
Nektar Completes Enrollment Ahead of Schedule in Phase 2 Clinical Trial Evaluating NKTR-102 in Patients with Platinum-Resistant Ovarian Cancer
Oct 28, 2009
PDF 10.2 KB
Phase 2 Data From Oral NKTR-118 Presented at American College of Gastroenterology in San Diego
Oct 27, 2009
PDF 11.2 KB
Topline Results from Phase 2 Clinical Trial of Oral NKTR-118 Presented at 20th American Academy of Pain Management Annual Clinical Meeting (AAPM) in Phoenix
Oct 10, 2009
PDF 11.4 KB
Nektar Therapeutics (NKTR) President and Chief Executive Officer to Ring The NASDAQ Stock Market Closing Bell
Sep 22, 2009
PDF 10.6 KB
NKTR-102 Shows Encouraging Anti-Tumor Activity in Ovarian Cancer in Phase 1 and Preclinical Data Presented at the ECCO 15 and 34th ESMO Multidisciplinary Congress
Sep 22, 2009
PDF 10.6 KB
Nektar Therapeutics to Host Conference Call to Discuss Today's Announcement of a New Partnership for NKTR-118 and NKTR-119
Sep 21, 2009
PDF 7.4 KB
AstraZeneca and Nektar Sign Worldwide Agreement for Nektar Drug Development Programmes -- NKTR-118 and NKTR-119 -- to Address Opioid-Induced Constipation
Sep 21, 2009
PDF 10.9 KB
Nektar Therapeutics to Present at the UBS 2009 Global Life Sciences Conference in New York City
Sep 18, 2009
PDF 6.1 KB
Showing 1-20 of 155 Page: 1 2 3 ... 8  Next 20
 
 
Site Map Privacy Terms of Use Compliance Policy Trademarks Site Users Guide